PAPERZILLA
Crunching Academic Papers into Bite-sized Insights.
About
Sign Out
← Back to papers

Life SciencesBiochemistry, Genetics and Molecular BiologyDevelopmental Biology

Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature
SHARE
Overview
Paper Summary
Conflicts of Interest
Identified Weaknesses
Rating Explanation
Good to know
Topic Hierarchy
File Information
Paper Summary
Paperzilla title
Beyond Floating-Harbor: SRCAP's Got a New Trick (and a DNAm Signature to Prove It!)
Truncating variants in SRCAP outside the Floating-Harbor syndrome (FLHS) locus cause a distinct neurodevelopmental disorder characterized by developmental delay, behavioral problems, and musculoskeletal issues. These individuals exhibit a unique DNA methylation signature that distinguishes them from FLHS, supporting the classification of this condition as a separate entity called non-FLHS SRCAP-related NDD.
Possible Conflicts of Interest
None identified.
Identified Weaknesses
Small sample size for distal SRCAP group
The sample size for individuals with distal SRCAP variants is small (n=5), limiting the statistical power and generalizability of findings related to this group.
Limited exploration of missense variants
The study focuses on truncating variants, and the impact of missense variants in SRCAP remains less explored, potentially overlooking a broader phenotypic spectrum.
Nonspecific clinical features
The clinical features of non-FLHS SRCAP-related NDD are nonspecific, making clinical diagnosis challenging and potentially leading to misdiagnosis or delayed diagnosis.
Limitations of facial recognition tools
Facial feature recognition tools were not entirely accurate in classifying individuals, highlighting the need for comprehensive clinical evaluation and additional diagnostic methods.
Rating Explanation
This study provides valuable insights into the phenotypic and molecular consequences of SRCAP variants outside the FLHS-causing locus, expanding our understanding of this gene's role in neurodevelopmental disorders. The identification of a distinct DNA methylation signature for non-FLHS SRCAP-related NDD is a significant contribution, enhancing diagnostic capabilities. While the small sample size for the distal SRCAP group and the nonspecific clinical features pose limitations, the overall methodology and findings are robust, warranting a rating of 4.
Good to know
This is our free standard analysis. Paperzilla Pro fact-checks every citation, researches author backgrounds and funding sources, and uses advanced AI reasoning for more thorough insights.
Explore Pro →
File Information
Original Title:
Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature
File Name:
234078.pdf
[download]
File Size:
3.12 MB
Uploaded:
July 14, 2025 at 11:26 AM
Privacy:
🌐 Public
© 2025 Paperzilla. All rights reserved.

If you are not redirected automatically, click here.